Thyroid dysfunction and autoimmune thyroid disease in women with polycystic ovarian syndrome: a case-control study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20261619Keywords:
Polycystic ovary syndrome, Thyroid dysfunction, Autoimmunity, Subclinical hypothyroidism, Anti-TPO antibodiesAbstract
Background: Polycystic ovarian syndrome (PCOS) is one of the most prevalent endocrine disorders affecting women of reproductive age. It is a multifactorial condition characterized by chronic anovulation, hyperandrogenism, and polycystic ovarian morphology. Emerging evidence suggests a link between PCOS and thyroid dysfunction, indicating shared pathophysiological and possibly autoimmune mechanisms. The main objective was to determine the prevalence of thyroid dysfunction and thyroid autoimmunity in women with PCOS and evaluate their association with clinical, metabolic, and endocrine parameters.
Methods: This hospital-based case–control study consisted of 126 women, comprising 63 cases diagnosed with PCOS and 63 age- and parity-matched healthy controls. Clinical, biochemical, and hormonal parameters were evaluated, including thyroid function tests (TSH and FT4), anti-thyroid peroxidase antibodies (anti-TPO), lipid profile, glucose metabolism, and gonadotropin levels. Data were analysed using SPSS version 20, with p<0.05 considered statistically significant.
Results: Thyroid dysfunction was significantly higher among PCOS women (26.98%) than controls (7.9%) (p=0.015). Subclinical hypothyroidism was the most frequent thyroid disorder (23.8% vs 7.9%). Anti-TPO antibody positivity was observed in 15.9% of PCOS women compared to 1.6% of controls (p=0.005). PCOS participants had higher BMI, triglycerides, total cholesterol, fasting glucose, HbA1c, LH and LH/FSH ratio, and free testosterone levels than controls.
Conclusions: Thyroid dysfunction and autoimmunity are significantly more prevalent among women with PCOS and appear to contribute to the metabolic and hormonal derangements characteristic of the syndrome. Routine screening for thyroid function and autoimmunity should be integral to the clinical evaluation and management of PCOS.
References
Patil S, Ramesh S, Murthy Kharidhi HS. A prospective analysis of polycystic ovarian syndrome in infertile women. Int J Reprod Contracept Obstet Gynecol. 2018;8(1):299-302.
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602-18.
Mueller A, Schöfl C, Dittrich R, Cupisti S, Oppelt PG, Schild RL, et al. Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome. Hum Reprod. 2009;24(11):2924-30.
Arduc A, Aycicek DB, Bilmez S, Imga Nasiroglu N, Tuna MM, Isik S, et al. High prevalence of Hashimoto’s thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role? Endocr Res. 2015;40(4):204-10.
Sinha U, Sinha RK, Saha S, Longkumer TA, Baul SN, Pal SK. Thyroid disorders in polycystic ovarian syndrome subjects: a tertiary hospital-based cross-sectional study from Eastern India. Indian J Endocrinol Metab. 2013;17(2):304-9.
Raj D, Pooja FN, Chhabria P, Kalpana FN, Lohana S, Lal K, et al. Frequency of subclinical hypothyroidism in women with polycystic ovary syndrome. Cureus. 2021;13:9.
Garelli S, Masiero S, Plebani M, Chen S, Furmaniak J, Armanini D, Betterle C. High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reproduct Biol. 2013;169(2):248-51.
Janssen OE, Mehlmauer N, Hahn S, Öffner AH, Gärtner R. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Europ J Endocrinol. 2004;150(3):363-9.
Kachuei M, Jafari F, Kachuei A, Keshteli AH. Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Arch Gynecol Obstet. 2012;285(3):853-6.
Yu Q, Wang JB. Subclinical Hypothyroidism in PCOS: Impact on Presentation, Insulin Resistance, and Cardiovascular Risk. Biomed Res Int. 2016;2016:2067087.
Celik C, Abali R, Tasdemir N, Guzel S, Yuksel A, Aksu E, Yılmaz M. Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome? Gynecoll Endocrinol. 2012;28(8):615-8.
Pergialiotis V, Konstantopoulos P, Prodromidou A, Florou V, Papantoniou N, Perrea DN. Management of endocrine disease: the impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of PCOS patients: a systematic review and meta-analysis. Eur J Endocrinol. 2017;176(3):R159-66.
Van der Ham K, Stekelenburg KJ, Louwers YV, van Dorp W, Schreurs MW, Van der Wal R, et al. The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS. Front Endocrinol (Lausanne). 2023;14:1245106.
Serin AN, Birge Ö, Uysal A, Görar S, Tekeli F. Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels. BMC Endocrine Disorders. 2021;21:1-8.
Arduc A, Aycicek Dogan B, Bilmez S, Imga Nasiroglu N, Tuna MM, Isik S, Berker D, Guler S. High prevalence of Hashimoto’s thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role? Endocrine Res. 2015;40(4):204-10.
Bedaiwy MA, Abdel-Rahman MY, Tan J, Abdel Hafez FF, Abdel kareem AO, Henry D, et al. Clinical, hormonal, and metabolic parameters in women with subclinical hypothyroidism and polycystic ovary syndrome: a cross-sectional study. J Womens Health (Larchmt). 2018;27(5):659-64.
Xing Y, Chen J, Liu J, Ma H. The impact of subclinical hypothyroidism on patients with polycystic ovary syndrome: a meta-analysis. Horm Metab Res. 2021;53(6):382-90.
Downloads
Published
How to Cite
Issue
Section
